Mei-Yin Polley to Research Design
This is a "connection" page, showing publications Mei-Yin Polley has written about Research Design.
Connection Strength
1.231
-
Power estimation in biomarker studies where events are already observed. Clin Trials. 2017 Dec; 14(6):621-628.
Score: 0.471
-
Two-stage designs for dose-finding trials with a biologic endpoint using stepwise tests. Biometrics. 2008 Mar; 64(1):232-41.
Score: 0.233
-
Leveraging external data in the design and analysis of clinical trials in neuro-oncology. Lancet Oncol. 2021 10; 22(10):e456-e465.
Score: 0.157
-
Comparison of confidence interval methods for an intra-class correlation coefficient (ICC). BMC Med Res Methodol. 2014 Nov 22; 14:121.
Score: 0.098
-
Criteria for the use of omics-based predictors in clinical trials. Nature. 2013 Oct 17; 502(7471):317-20.
Score: 0.090
-
Randomized phase II trial designs with biomarkers. J Clin Oncol. 2012 Sep 10; 30(26):3304-9.
Score: 0.083
-
Practical modifications to the time-to-event continual reassessment method for phase I cancer trials with fast patient accrual and late-onset toxicities. Stat Med. 2011 Jul 30; 30(17):2130-43.
Score: 0.076
-
Criteria for the use of omics-based predictors in clinical trials: explanation and elaboration. BMC Med. 2013 Oct 17; 11:220.
Score: 0.023